Up to 20% of all ischemic strokes are felt to be the result of emboli
from the heart. High resolution transthoracic (TTE) and transesophagea
l (TEE) echocardiography have been the principal diagnostic tools for
detecting associated cardiac abnormalities and for guiding medical and
surgical approaches to these patients. In addition to identifying the
precise location and morphological characteristics of intracardiac ma
sses, echocardiography has improved our ability to predict embolic pot
ential of these masses. Specific cardiac lesions that are predisposed
to stroke and are readily identifiable by echocardiography include: ca
rdiac thrombi, valvular vegetations, cardiac tumors, aortic atheroma,
atrial septal aneurysm, and regional left ventricular wall abnormaliti
es. Careful interrogation of patients with cerebrovascular accidents h
as identified a potential cardiac source of embolus in approximately 3
0%. This is largely due to the advent of TEE, which has provided much
better assessment of posterior cardiac chambers including left atrium
and left atrial appendage. Use of TEE in identifying a cardiac source
of embolus is indicated inpatients with stroke who are young, have no
apparent cerebrovascular disease, or have recurrent embolic events. Ec
hocardiography is an essential diagnostic tool in evaluating patients
with a suspected cardiac source of embolus. TTE and TEE provide invalu
able information regarding the majority of cardiac sources of embolus.